Rating Change
Canaccord Genuity reiterated its Buy rating on Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) on October 20, 2026.
reiterateNASDAQ:GUTS
Canaccord Genuity Reiterates Buy Rating on Fractyl Health, Inc. Common Stock (GUTS)
Canaccord Genuity reiterated its Buy rating on Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) on October 20, 2026.
At publication ·
What changed
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) · reiterate
- Firm
- Canaccord Genuity
- Rating
- Buy to Buy
- Price at event
- $1.33
- Market capitalization
- $166.4M
At a glance
Key takeaways
- Canaccord Genuity reiterated a Buy rating on Fractyl Health (GUTS) on October 20, 2026, while the stock trades at $1.33 with a market cap of $166.4 million.
Market Context
Fractyl Health, Inc. Common Stock operates in the Healthcare sector. The stock currently trades at $1.33 with a market capitalization of $166.4M.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Fractyl Health, Inc. Common Stock.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Fractyl Health, Inc. Common Stock
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 20, 2026 | Canaccord Genuity | Buy | N/A |
| Oct 19, 2026 | Morgan Stanley | Equal-Weight | N/A |
| Jul 01, 2026 | Craig-Hallum | Buy | N/A |
| Jun 04, 2026 | HC Wainwright & Co. | Buy | N/A |
| Apr 24, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View GUTS Stock Page
Frequently Asked Questions
What does the Buy rating mean for GUTS?
A rating of Buy from Canaccord Genuity reflects the analyst's outlook on Fractyl Health, Inc. Common Stock (NASDAQ:GUTS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GUTS forecast page.